HomeInvesting NewsModerna to Give Canada Omicron-Based COVID Vaccine Including 12 Million Doses

Moderna to Give Canada Omicron-Based COVID Vaccine Including 12 Million Doses

Published on

Moderna (NASDAQ:MRNA) said it would give the Canadian government 12 million doses of its Omicron-containing bivalent vaccine booster as part of an agreement made last year to supply COVID-19 vaccine doses.

It is projected that all of these doses will be administered by the end of 2022. We would like to inform you that the Canadian health authorities have not yet given their blessing to the Omicron-specific bivalent vaccine.

The Canadian government has made good on its plan to buy an additional 4.5 million doses of the bivalent vaccination booster produced by Moderna and including the Omicron antigen. Additionally, 1.5 million medicines slated for delivery in 2022 will be shipped out early by the corporation.

Additionally, the parties have settled on exchanging a request for 6 million doses of Spikevax for a bivalent vaccine booster, including Omicron.

Compared to the industry’s 21.9% decrease this year, Moderna’s stock price is down 43.9%.

To the Canadian government’s delight, Moderna secured a supply contract for its COVID vaccination in 2022 and 2023. Up to 65 million doses will be purchased by the government annually. The Canadian government has the option to prolong the deal through the year 2024 so that they can continue benefiting from it. Canada can buy new vaccine adaptations from Moderna as part of the deal.

The business recently released trial data for their bivalent COVID-19 vaccine booster candidate, mRNA-1273.214, designed to combat the Omicron form.

Clinical Data from Moderna

New clinical data showed that after a month of administration, participants who received a 50 g dose of mRNA-1273.214 (regardless of prior infection or age) generated higher neutralizing antibodies against the Omicron subvariants BA.4 and BA.5 compared with those who received a booster dose of Spikevax.

Additionally, Moderna has created mRNA-1273.222, a bivalent booster candidate that includes both the company’s first vaccination, Spikevax, and the Omicron BA.4/5 strain mRNA. It is believed that Moderna will shortly submit a EUA application to the FDA.

Indeed, mRNA-1273.222 development began when the FDA suggested vaccination manufacturers create bivalent booster vaccines specific to Omicron BA.4 and BA.5 subvariants. After months of negotiations, Moderna said it had signed an advance purchase agreement with the United States government to supply up to 300 million mRNA-1273.222 doses for $1.74 billion.

Featured Image:  Megapixl © Boarding1now

See Disclaimer Please

Latest News

Recent Surge in Tesla Stock: Exactly What Caused It?

Tesla Stock (NASDAQ:TSLA) As of 11:30 a.m ET on Friday, Tesla stock was up 2.3%...

Here’s Why Carvana Stock Fell Quite So Much as 23.7% This Week

Carvana Stock (NYSE:CVNA) According to data provided by S&P Global Market Intelligence, Carvana stock fell...

Here’s Why Tellurian Stock Is Rising Again Today

Tellurian Stock (NYSEMKT:TELL) Tellurian stock was up 6.5% as of 11:06 p.m. ET today after...

Is It Time to Buy Chewy Stock?

Chewy Stock (NYSE:CHWY) Pet supplies are one of the few consumer goods that do well,...

More like this

2 Casino Stocks You Should Consider

With a recession on the horizon, investors must be more selective than ever. Analysts...

(Exxon Mobil Stock) Exxon Ceo Warns Biden Administration Against Restricting Fuel Exports

Exxon (Exxon Mobil Stock) opposes calls for oil corporations to reduce international exports and...

Apple Stock Loses $120 Billion Because of a Rare Downgrade

Apple stock just took a significant knock after it was once considered to be...

Meta Stock Tops Morningstar List of the Most Undervalued Stocks 

Morningstar compiled a list of the most undervalued stocks among those with a large...

Hd Stock up as Foundation to Contribute Up to $1 Million to Aid Communities Affected by Hurricane Ian

HD stock was trading at $280.23 as of 12:55 PM EDT. The Home Depot Foundation...

Making the Cut: Micron (Micron Stock)

Micron Technology Inc (Micron Stock) latest outlook brings expectations back to normal, although the...